反応式
CN1CCOCC1.[N+:8]([C:11]1[CH:16]=[CH:15][C:14]([C:17]2[S:21][C:20]([C:22]([O:24]CC)=O)=[N:19][CH:18]=2)=[CH:13][CH:12]=1)([O-:10])=[O:9].ClC(OCC(C)C)=O.Cl.[CH3:36][O:37][C:38](=[O:44])[C@H:39]([CH:41]([CH3:43])[CH3:42])[NH2:40]>C1COCC1.CCN(CC)CC>[CH3:42][CH:41]([CH3:43])[CH:39]([NH:40][C:22]([C:20]1[S:21][C:17]([C:14]2[CH:13]=[CH:12][C:11]([N+:8]([O-:10])=[O:9])=[CH:16][CH:15]=2)=[CH:18][N:19]=1)=[O:24])[C:38]([O:37][CH3:36])=[O:44]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 2
実験手順
N-methyl morpholine (1.01 ml) was added to a solution of 5-(4-nitrophenyl)thiazole-2-carboxylic acid (Intermediate 2, step B, 2.3 g) in THF (72 ml). The reaction mixture was stirred for 10 minutes at RT, cooled to −20° C. Isobutyl chloroformate (1.19 ml) was added and the mixture was stirred for 15-20 minutes at −20 to −30° C. This was followed by the addition of L-valine methyl ester hydrochloride (2.15 g) previously neutralized with Et3N (1.8 ml). The reaction mixture was stirred at −20 to −30° C. for 5 minutes and was then allowed to gradually warm to RT. The solvent was removed under reduced pressure and the crude material was chromatographed on silica gel in 15:85 EtOAc:CHCl3 to get pale yellow colored solid which was crystallized in EtOAc/Pet ether to yield 2.25 g (67%) of the title compound. 1H NMR (DMSO-d6, 300 MHz): δ 8.95 (d, 1H), 8.7 (s, 1H), 8.34 (d, 2H), 8.09 (d, 2H), 4.33 (m, 1H), 3.68 (s, 3H), 2.27 (m, 1H), 0.95 (t, 6H); MS (ES+): m/z 364 (M+1).
後処理
- temperaturecooled to −20° C
- stirringthe mixture was stirred for 15-20 minutes at −20 to −30° C
- stirringThe reaction mixture was stirred at −20 to −30° C. for 5 minutes
- temperatureto gradually warm to RT
- customThe solvent was removed under reduced pressure
- customthe crude material was chromatographed on silica gel in 15:85 EtOAc
- customCHCl3 to get pale yellow colored solid which
- customwas crystallized in EtOAc/Pet ether
出典と根拠
- ORDレコード
- ord-5eb77b1a090848bd992832277debbd67
- 出典データセット
- uspto-grants-2014_05
- 特許番号
- US08722901B2
関連ノート
読み込み中…